Chiropractors in Bloomington, IN Accepting Medicare
64 Chiropractors found. Showing 61 - 64
 Indiana Chiropractic And Rehab Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 100 N Curry Pike, Bloomington, IN 47404 Phone: 812-340-3805 |
Bright Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 2215 S Curry Pike, Bloomington, IN 47403 Phone: 812-332-4150 |
 Henry Smaltz, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 565 N Walnut St, Bloomington, IN 47404 Phone: 812-336-2423 Fax: 812-331-2792 |
Dr. Craig Foster Morrow, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 116 East Third Street, Bloomington, IN 47401 Phone: 812-333-1206 Fax: 812-961-0341 |
News Archive
Researchers find novel drug target for anaplastic thyroid carcinomas
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
Study finds PCV7 vaccine reduces bacterial pneumonia infection in children
The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, according to a new study published today in the journal Thorax.
Bluetooth helps battle COVID-19
As the novel coronavirus pandemic sweeps the globe, contact tracing has taken the spotlight as epidemiologists scramble to identify and isolate potential vectors for the disease. Limited technology has forced authorities to fall back on manual methods, which are both time-consuming and limited in reliability since they depend on the ability of the infected individual to remember all the places and persons he/she has been in contact with.
Pulmatrix announces positive results from Phase 1 study of novel dry powder formulation in COPD patients
Pulmatrix, Inc., today announced positive topline data from a Phase 1 pilot pharmacokinetic bioavailability trial of PUR0200. PUR0200 is a novel dry powder formulation of a currently marketed once daily bronchodilator, formulated in the company's proprietary iSPERSETM dry powder delivery technology.
› Verified 2 days ago
Physical Therapists
Optometrists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Audiologists
Podiatrists